ERBB2 and breast cancer: Recently, there has been an increasing interest in leveraging the power of artificial intelligence (AI) to identify HER2 status in BC from tumour morphology using the digitalised H&E‐stained slides [21, 22, 23, 24, 25, 26, 27, 28].